This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LOBO, R. A. Search for Related Content PubMed PubMed Citation Articles by LOBO, R. A.

CLINICAL REVIEW 27 Effects of Hormonal Replacement on Lipids and Lipoproteins in Postmenopausal Women

Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Southern California School of Medicine Los Angeles, California 90033

Address requests for reprints to: Dr. Rogerio A. Lobo, Division of Reproductive Endocrinology, Women's Hospital, Room 1M2, Los Angeles County-University of Southern California Medical Center, 1240 North Mission Road, Los Angeles, California 90033.

HEART disease is the leading cause of death in women and accounts for 500,000 deaths annually, compared to only 250,000 for cancer. Of the $60 billion spent annually in the United States for the treatment of heart disease, 58% of this expense is attributable to disease in women. Unfortunately, however, virtually all appropriations of funding for research in the prevention and treatment of heart disease are for men. Several lines of evidence suggest that both the morbidity and mortality of heart disease in postmenopausal women are increased compared to those in men. Heart disease after menopause is a more devastating disease. The focus of this review, therefore, is to explore the hypothesis that lipids may be implicated in this cardiovascular (CV) risk and to analyze the effects of hormonal replacement therapy (HRT) on lipids and lipoproteins.

Cardiovascular Disease: The Influence of Cholesterol

The incidence of cardiovascular disease (CVD) rises substantially with aging after the natural menopause, but only equates the incidence in men in the seventh decade.

Received May 24, 1991.

This article has been cited by other articles:

				J. R. Meendering, B. N. Torgrimson, N. P. Miller, P. F. Kaplan, and C. T. Minson Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1630 - H1637. [Abstract] [Full Text] [PDF]

				G. Corrao, A. Zambon, V. Conti, F. Nicotra, C. La Vecchia, C. Fornari, G. Cesana, P. Contiero, G. Tagliabue, R. E. Nappi, et al. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation Ann. Onc., January 1, 2008; 19(1): 150 - 155. [Abstract] [Full Text] [PDF]

				N. L. Smith, S. R. Heckbert, R. N. Lemaitre, A. P. Reiner, T. Lumley, N. S. Weiss, E. B. Larson, F. R. Rosendaal, and B. M. Psaty Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis JAMA, October 6, 2004; 292(13): 1581 - 1587. [Abstract] [Full Text] [PDF]

				F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]

				R. N. Lemaitre, S. R. Heckbert, B. M. Psaty, N. L. Smith, R. C. Kaplan, and W. T. Longstreth Jr Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women Arch Intern Med, September 23, 2002; 162(17): 1954 - 1960. [Abstract] [Full Text] [PDF]

				F. Cucinelli, L. Soranna, D. Romualdi, G. Muzj, S. Mancuso, and A. Lanzone The Effect of Raloxifene on Glyco-Insulinemic Homeostasis in Healthy Postmenopausal Women: A Randomized Placebo-Controlled Study J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4186 - 4192. [Abstract] [Full Text] [PDF]

				I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338. [Abstract] [Full Text] [PDF]

				I. R. Pirwany, N. Sattar, I. A. Greer, C. J. Packard, and R. Fleming Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles Hum. Reprod., March 1, 2002; 17(3): 825 - 829. [Abstract] [Full Text] [PDF]

				C.-L. Chen, N. S. Weiss, P. Newcomb, W. Barlow, and E. White Hormone Replacement Therapy in Relation to Breast Cancer JAMA, February 13, 2002; 287(6): 734 - 741. [Abstract] [Full Text] [PDF]

				G. Marra, P. Cotroneo, D. Pitocco, A. Manto, M. A.S. Di Leo, V. Ruotolo, S. Caputo, B. Giardina, G. Ghirlanda, and S. A. Santini Early Increase of Oxidative Stress and Reduced Antioxidant Defenses in Patients With Uncomplicated Type 1 Diabetes: A case for gender difference Diabetes Care, February 1, 2002; 25(2): 370 - 375. [Abstract] [Full Text] [PDF]

				K. I. Pritchard Hormone Replacement in Women with a History of Breast Cancer Oncologist, August 1, 2001; 6(4): 353 - 362. [Abstract] [Full Text] [PDF]

				T. Naessen, K. Rodriguez-Macias, and H. Lithell Serum Lipid Profile Improved by Ultra-Low Doses of 17{beta}-Estradiol in Elderly Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2757 - 2762. [Abstract] [Full Text] [PDF]

				E. S. O'Meara, M. A. Rossing, J. R. Daling, J. G. Elmore, W. E. Barlow, and N. S. Weiss Hormone Replacement Therapy After a Diagnosis of Breast Cancer in Relation to Recurrence and Mortality J Natl Cancer Inst, May 16, 2001; 93(10): 754 - 761. [Abstract] [Full Text] [PDF]

				M. Otsuki, H. Saito, X. Xu, S. Sumitani, H. Kouhara, T. Kishimoto, and S. Kasayama Progesterone, but Not Medroxyprogesterone, Inhibits Vascular Cell Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, February 1, 2001; 21(2): 243 - 248. [Abstract] [Full Text] [PDF]

				M. Seed, R. H Sands, M. McLaren, G. Kirk, and D. Darko The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women Fam. Pract., December 1, 2000; 17(6): 497 - 507. [Abstract] [Full Text] [PDF]

				L. Mosca The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease Arch Intern Med, August 14, 2000; 160(15): 2263 - 2272. [Abstract] [Full Text] [PDF]

				A. Karjalainen, J. Heikkinen, M. J. Savolainen, A.-C. Backstrom, and Y. A. Kesaniemi Mechanisms Regulating LDL Metabolism in Subjects on Peroral and Transdermal Estrogen Replacement Therapy Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1101 - 1106. [Abstract] [Full Text] [PDF]

				B. M. Wolfe, P. H. R. Barrett, L. Laurier, and M. W. Huff Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women J. Lipid Res., March 1, 2000; 41(3): 368 - 375. [Abstract] [Full Text]

				A.S Fak, M Erenus, H Tezcan, O Caymaz, P AtagunduZ, S Oktay, and A Oktay Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women Eur. Heart J., February 1, 2000; 21(3): 190 - 197. [Abstract] [PDF]

				K. T. Barnhart, E. Freeman, J. A. Grisso, D. J. Rader, M. Sammel, S. Kapoor, and J. E. Nestler The Effect of Deydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3896 - 3902. [Abstract] [Full Text]

				S. C. Lim, A. E. Caballero, S. Arora, P. Smakowski, E. M. Bashoff, F. M. Brown, F. W. Logerfo, E. S. Horton, and A. Veves The Effect of Hormonal Replacement Therapy on the Vascular Reactivity and Endothelial Function of Healthy Individuals and Individuals with Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4159 - 4164. [Abstract] [Full Text]

				K. Rödström, C. Bengtsson, L. Lissner, and C. Björkelund Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden BMJ, October 2, 1999; 319(7214): 890 - 893. [Abstract] [Full Text]

				J. V. Pinkerton and R. Santen Alternatives to the Use of Estrogen in Postmenopausal Women Endocr. Rev., June 1, 1999; 20(3): 308 - 320. [Abstract] [Full Text]

				B. Fowble, A. Hanlon, G. Freedman, A. Patchefsky, H. Kessler, N. Nicolaou, J. Hoffman, E. Sigurdson, M. Boraas, and L. Goldstein Postmenopausal Hormone Replacement Therapy: Effect on Diagnosis and Outcome in Early-Stage Invasive Breast Cancer Treated With Conservative Surgery and Radiation J. Clin. Oncol., June 1, 1999; 17(6): 1680 - 1680. [Abstract] [Full Text] [PDF]

				F. C. W. Wu, R. Balasubramanian, T. M. T. Mulders, and H. J. T. Coelingh-Bennink Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 112 - 122. [Abstract] [Full Text]

				W. Cheng, O. D. Lau, and N. A. Abumrad Two Antiatherogenic Effects of Progesterone on Human Macrophages; Inhibition of Cholesteryl Ester Synthesis and Block of Its Enhancement by Glucocorticoids J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 265 - 271. [Abstract] [Full Text]

				M. S. Weintraub, I. Grosskopf, G. Charach, N. Eckstein, Y. Ringel, N. Maharshak, H. H. Rotmensch, and A. Rubinstein Fluctuations of Lipid and Lipoprotein Levels in Hyperlipidemic Postmenopausal Women Receiving Hormone Replacement Therapy Arch Intern Med, September 14, 1998; 158(16): 1803 - 1806. [Abstract] [Full Text] [PDF]

				F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 999 - 1006. [Abstract] [Full Text] [PDF]

				D. F. Skafar, R. Xu, J. Morales, J. Ram, and J. R. Sowers Female Sex Hormones and Cardiovascular Disease in Women J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3913 - 3918. [Abstract] [Full Text] [PDF]

				G. E. Croston, L. B. Milan, K. B. Marschke, M. Reichman, and M. R. Briggs Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes Endocrinology, September 1, 1997; 138(9): 3779 - 3786. [Abstract] [Full Text] [PDF]

				G. M. Darling, J. A. Johns, P. I. McCloud, and S. R. Davis Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women N. Engl. J. Med., August 28, 1997; 337(9): 595 - 601. [Abstract] [Full Text] [PDF]

				P. Holm, S. Stender, H. o. Andersen, B. F. Hansen, and B. G. Nordestgaard Antiatherogenic Effect of Estrogen Abolished by Balloon Catheter Injury in Cholesterol-Clamped Rabbits Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1504 - 1511. [Abstract] [Full Text]

				S. R. Heckbert, N. S. Weiss, T. D. Koepsell, R. N. Lemaitre, N. L. Smith, D. S. Siscovick, D. Lin, and B. M. Psaty Duration of Estrogen Replacement Therapy in Relation to the Risk of Incident Myocardial Infarction in Postmenopausal Women Arch Intern Med, June 23, 1997; 157(12): 1330 - 1336. [Abstract] [PDF]

				J. C. LaRosa Triglycerides and Coronary Risk in Women and the Elderly Arch Intern Med, May 12, 1997; 157(9): 961 - 968. [Abstract] [PDF]

				T. Mizokami, K. Okamura, K. Sato, T. Kuroda, S. Sadoshima, and M. Fujishima Risk Factors for Brain Infarction in Patients with Cushing's Disease: Case Reports Angiology, October 1, 1996; 47(10): 1011 - 1017. [Abstract] [PDF]

				M.-R. Taskinen, J. Puolakka, T. Pyorala, H. Luotola, M. Bjorn, J. Kaariainen, S. Lahdenpera, and C. Ehnholm Hormone Replacement Therapy Lowers Plasma Lp(a) Concentrations: Comparison of Cyclic Transdermal and Continuous Estrogen-Progestin Regimens Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1215 - 1221. [Abstract] [Full Text]

				C. J. Kim, Y. K. Min, W. S. Ryu, J. W. Kwak, and U. H. Ryoo Effect of Hormone Replacement Therapy on Lipoprotein(a) and Lipid Levels in Postmenopausal Women: Influence of Various Progestogens and Duration of Therapy Arch Intern Med, August 12, 1996; 156(15): 1693 - 1700. [Abstract] [PDF]

				V. Guetta and R. O. Cannon III Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women Circulation, May 15, 1996; 93(10): 1928 - 1937. [Full Text]

				J. K. Williams, M. S. Anthony, E. K. Honore, D. M. Herrington, T. M. Morgan, T. C. Register, and T. B. Clarkson Regression of Atherosclerosis in Female Monkeys Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 827 - 836. [Abstract] [Full Text]

				The Writing Group for the PEPI Trial, V. T. Miller, J. LaRosa, V. Barnabei, C. Kessler, G. Levin, A. Smith-Roth, M. Griffin, D. B. Stoy, T. Bush, et al. Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA, January 18, 1995; 273(3): 199 - 208. [Abstract] [PDF]

				B. M. Psaty, S. R. Heckbert, D. Atkins, R. Lemaitre, T. D. Koepsell, P. W. Wahl, D. S. Siscovick, and E. H. Wagner The Risk of Myocardial Infarction Associated With the Combined Use of Estrogens and Progestins in Postmenopausal Women Arch Intern Med, June 27, 1994; 154(12): 1333 - 1339. [Abstract] [PDF]

				P. E. Belchetz Hormonal Treatment of Postmenopausal Women N. Engl. J. Med., April 14, 1994; 330(15): 1062 - 1071. [Full Text]

				S. R. Lindheim, T. A. Buchanan, D. M. Duffy, M. A. Vijod, T. Kojima, F. Z. Stanczyk, and R. A. Lobo Original ArticlesComparison of Estimates of Insulin Sensitivity in Pre- and Postmenopausal Women Using the Insulin Tolerance Test and the Frequently Sampled Intravenous Glucose Tolerance Test Reproductive Sciences, April 1, 1994; 1(2): 150 - 154. [Abstract] [PDF]

				M. A. Denke, C. T. Sempos, and S. M. Grundy Excess Body Weight: An Under-recognized Contributor to Dyslipidemia in White American Women Arch Intern Med, February 28, 1994; 154(4): 401 - 410. [Abstract] [PDF]

				S. R. Lindheim, R. S. Legro, R. S. Morris, I. L. Wong, D. Q. Tran, M. A. Vijod, F. Z. Stanczyk, and R. A. Lobo The Effect of Progestins on Behavioral Stress Responses in Postmenopausal Women Reproductive Sciences, January 1, 1994; 1(1): 79 - 83. [Abstract] [PDF]

				R. S. Rosenson Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management Arch Intern Med, July 12, 1993; 153(13): 1528 - 1538. [Abstract] [PDF]

				B. M. Psaty, S. R. Heckbert, D. Atkins, D. S. Siscovick, T. D. Koepsell, P. W. Wahl, W. T. Longstreth Jr, N. S. Weiss, E. H. Wagner, R. Prentice, et al. A Review of the Association of Estrogens and Progestins With Cardiovascular Disease in Postmenopausal Women Arch Intern Med, June 28, 1993; 153(12): 1421 - 1427. [Abstract] [PDF]